• The number of total prevalent cases of MCI across the countries under study will increase by 48%, from 49 million in 2016 to 72 million in 2026.
  • Among the countries considered in this analysis, the total prevalence of MCI is highest in South Korea, at 208 per 1,000 aged 65 or over in 2016.

Table of contents

  • Mild Cognitive Impairment - Epidemiology - Emerging Markets Data

Author(s): Nishant Kumar, MPH

Nishant is a senior epidemiologist and head of oncology within the epidemiology team at Decision Resources Group. He also covers some CNS diseases, including Alzheimer’s disease and dementia. His key interests are developing interactive patient flows, and modelling disease progression to forecast commercially relevant drug-treatable incident and prevalent populations. Nishant also spends a lot of time collaborating with clients to help answer more specific questions through custom work and consulting projects.

His qualifications include an MSc in Public Health with specialization in epidemiology and statistics from King’s College London, and a BSc in Medical Studies from the University of Birmingham.